Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Gynecol Oncol. 2017 May 18;146(2):416–426. doi: 10.1016/j.ygyno.2017.05.010

Table 2.

Reported incidence of anemia associated with chemotherapeutic agents

Agent(s) Grade 1, 2 Grade 3, 4
Cisplatin 8% 11%
Carboplatin 66% 7–26%
Docetaxel 73–85% 2–10%
Paclitaxel 93% 0–12%
Topotecan 67% 30–40%
Gemcitabine 8–63% 2–5%
Cisplatin + etoposide 59% 16–55%
Cisplatin + paclitaxel 45–60% 5–25%
Carboplatin + paclitaxel 10–59% 3–34%
Dose dense paclitaxel + carboplatin 5–90% 10–57%